05:02 | Empowering Smart Enterprises: HashMicro's Role in Singapore's Digital Future |
05:00 | CJ 4DPLEX Outpaces Domestic Box Office Growth with Record-Breaking First Half of 2025 |
05:00 | Xuan Wu Cloud Wind ESG rating upgraded to A level, accompanied by exceptional sustainability performance |
|
05:00 | Korean Ginseng Makes a Strong Debut in Taiwan! K-Food Teams Up with Taiwanese Sports Stars to Launch a New Wave of Health Trends |
04:49 | dpa-AFX KUNDEN-INFO: Finanzanalysen in den dpa-AFX Diensten |
04:39 | Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection |
04:37 | Forrester's 2026 Budget Planning Guides: Leaders Grow More Cautious As Economic Uncertainty Persists |
04:35 | Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection |
04:32 | Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors |
04:17 | Medley Expands Operations in the Philippines to Accelerate Global Growth |
04:04 | Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection |
04:00 | OceanX Education Welcomes Science Engagement Leader Prof. Tit Meng Lim as APAC Regional Executive Director |
04:00 | Otis Enhances Luxury Living with Sustainable and Innovative Mobility Solutions |
04:00 | New Azul and ITAM Forum Survey Reveals 1 in 4 Organizations Spend More Than $500,000 Annually Resolving Software License Non-Compliance |
03:57 | Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection |
03:57 | Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection |
03:52 | Tesla-Aktie unter Druck: Politische Kontroversen und Absatzrückgänge belasten - nächste Hürde naht |
03:47 | Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer |
03:35 | Tesla-Aktie im Visier: Elon Musk schießt gegen Analysten - "Halt die Klappe" |
03:29 | Hier bleibt Krypto steuerfrei: Die attraktivsten Länder für Bitcoin & Co. |
03:27 | Vantage glänzt auf der Money Expo Colombia 2025 mit Branchenanerkennung und dynamischem Engagement |
03:25 | Rekordhalbjahr für Europas ETF-Sektor: SIX profitiert vom starken Zuwachs |
03:22 | Der Bericht von TOPDON und der globalen Business-Intelligence-Plattform Statista zeigt einen zunehmenden Trend weg von der Abhängigkeit von Mechanikern hin zur eigenständigen Fahrzeugwartung |
03:20 | JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures |
03:18 | Börsenneuling unter der Lupe: So lief es seit dem IPO für die Circle Internet-Aktie |
03:17 | NVIDIA-CEO Jensen Huang verkauft Millionen von Aktien - Kein Grund zur Sorge für Anleger? |
03:16 | Binance-Gründer Changpeng Zhao erklärt Bitcoin-Besitz zum neuen amerikanischen Traum |
03:11 | Trotz 4-Billionen-Marktkapitalisierung: Jim Cramer weiter bullish für NVIDIA |
03:11 | Diese Städte sind die unfreundlichsten der Welt |
03:10 | Fernbusreisen: Günstige Alternative, um entspannt ans Ziel zu kommen |
03:00 | Frontera Announces Normal Course Issuer Bid |
03:00 | Markel appoints Chelsea Jiang as Managing Director - Greater China |
03:00 | TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide |
03:00 | ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO |
03:00 | Markel appoints Chelsea Jiang as Managing Director - Greater China |
03:00 | ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO |
03:00 | ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO |
03:00 | AbbVie's 10th 'Week of Possibilities' Unites Employees Across Asia for Community Impact |
03:00 | Frontera Announces Normal Course Issuer Bid |
03:00 | Markel appoints Chelsea Jiang as Managing Director - Greater China |
02:54 | PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test |
02:45 | NetGain Systems Launches Astra AI, the World's First Large Language Model Purpose-Built for IT Asset Observability and Management |
02:44 | PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test |
02:39 | Crown Concepts Acquires Radical Arizona, Expands Partnership with Radical Motorsport |
02:33 | Autonomous Agents Set to Revolutionise Transportation Management |
02:31 | Classic Wines of California Announces Key New Partnerships and Leadership Expansion |
02:29 | Frontera Announces Completion of Substantial Issuer Bid |
02:29 | Frontera Announces Completion of Substantial Issuer Bid |
02:29 | Cogeco Announces Q3 2025 Financial Results and Canadian Wireless Launch |
02:28 | Cogeco Communications Announces Q3 2025 Financial Results and Canadian Wireless Launch |